Santa Farma Signs New Agreement with MEALIS

Santa Farma continues its strategic partnership with MEALIS Middle East Life Sciences, which has been ongoing since 2020, by signing a new agreement. In recent years, a new agreement has been added to the sales, marketing and distribution agreements signed for 2 different products used in the treatment of iron deficiency anemia and stress urinary incontinence. With the newly signed agreement, the Turkey sales, marketing and distribution rights for a medication used in the treatment of symptoms such as pain, loss of sensation and loss of strength in the extremities of the body caused by peripheral nerve damage, known as diabetic neuropathy in diabetes, have been transferred to MEALIS.   Santa Farma Santa Farma, one of Turkey's most established pharmaceutical companies and celebrating its 79th year, entered the sector in 1944 as Farma Laboratory with simple but widely-used medicines such as pesticide products, cough tablets and syrup. As a result of the merger with Santa Laboratory in 1946, the foundations of today's Santa Farma were laid. In 1953, a decision was made to establish a production facility. Santa Farma Drug Factory Collective Company was established in 1954, and Santa Farma Pharmaceutical Industry Inc. was founded in 1973. Santa Farma operates with a total of 73 products across 10 different therapeutic categories and 50 different markets under these categories. The therapeutic categories in question are listed as Dermatology, Digestive System and Metabolism, Gastroenterology and Infection, Hematology, Cardiovascular System, Musculoskeletal System, Radiology, Nervous System (CNS), Respiratory System, Urogenital System. The company's production facility in GEBKIM OSB operates with a production capacity of 150 million boxes per year in a closed area of 44,000 m2. For more detailed information, you can visit the www.santafarma.com.tr website. Mealis Mealis Turkey, which is among Turkey's most prestigious sales, marketing and distribution organizations, began its operations in 2014 with the sales, marketing and distribution of original contrast agents used in the field of radiology and the medical devices used with them. In 2015, within the framework of an international exclusive partnership signed in the field of women's health, it undertook the sales, distribution and marketing of original biological products, including the special distribution requirements of these products. In the following years, it continued to demonstrate a quality healthcare approach by utilizing the knowledge and experience of domestic and international business partners in its own marketing and sales processes. By providing nationwide comprehensive and effective scientific introduction services to healthcare professionals, it continues its operations with innovative and high value-added products that improve patients' quality of life, particularly in the fields of women's health and urology. For more detailed information, you can visit the www.mealisturkey.com website.